Lipid-siRNA conjugate accesses a perivascular transport mechanism and achieves widespread and durable knockdown in the central nervous system
Sorets, A.; Schwensen, K.; Francini, N.; Kjar, A.; Abdulrahman, A.; Shostak, A.; Katdare, K.; Schoch, K.; Cowell, R.; Park, J.; Ligocki, A.; Ford, W.; Ventura-Antunes, L.; Hoogenboezem, E.; Prusky, A.; Castleberry, M.; Michell, D. L.; Miller, T.; Vickers, K.; Schrag, M.; Duvall, C.; Lippmann, E.
Show abstract
Short-interfering RNA (siRNA) has gained significant interest for treatment of neurological diseases by providing the capacity to achieve sustained inhibition of nearly any gene target. Yet, efficacious drug delivery throughout deep brain structures of the CNS remains a considerable hurdle for intrathecally administered therapeutics. We herein describe an albumin-binding lipid-siRNA conjugate that transports along meningeal and perivascular CSF pathways, leading to broad dispersion throughout the CNS parenchyma. We provide a detailed examination of the temporal kinetics of gene silencing, highlighting potent knockdown for up to five months from a single injection without detectable toxicity. Single-cell RNA sequencing further demonstrates gene silencing activity across diverse cell populations in the parenchyma and at brain borders, which may provide new avenues for neurological disease-modifying therapies.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Intravenous lipid-siRNA conjugate mediates gene silencing at the blood-brain barrier and blood-CSF barrier 96%
- Advanced Peptide Nanoparticles Enable Robust and Efficient delivery of gene editors across cell types 94%
- Focused Ultrasound Augments the Delivery and Penetration of Model Therapeutics into Cerebral Cavernous Malformations 92%
Similar papers in this journal
- Bioengineering multifunctional extracellular vesicles for targeted delivery of biologics to T cells 93%
- Human spinal cord organoids exhibiting neural tube morphogenesis for a quantifiable drug screening system of neural tube defects 92%
- STRAIGHT-IN Dual: a platform for dual, single-copyintegrations of DNA payloads and gene circuits into human induced pluripotent stem cells 91%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.